Samsara BioCapital, 10% Owner: Kalaris Therapeutics KLRS Buy · Filed 05/22

Trade details

Type: Insider buy
Amount: $1,179,969
Shares · price: 244,300 sh · $4.83 a share
Held after: 2,224,147 sh
Stock: Kalaris Therapeutics KLRS
Person: Samsara BioCapital10% Owner
Trade date: 26/05/20
Filed: 26/05/22
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 5 insiders
Holding change: +12.3%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 04/20~06/19

Samsara BioCapital's recent trades

Samsara BioCapital10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$5M
479,847 sh
$5M
Filed 02/17
Traded 25/12/18
Samsara BioCapital10% Owner
BuyMineralys Therapeutics
Buy
Mineralys Therapeutics
MLYS
$8.1M
600,000 sh
$8.1M
Filed 25/03/17
Traded 25/03/13
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$516.8K
20,748 sh
$516.8K
Filed 24/11/27
Traded 24/11/26
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$406.8K
15,219 sh
$406.8K
Filed 24/11/27
Traded 24/11/26
Samsara BioCapital10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$281K
10,803 sh
$281K
Filed 24/11/27
Traded 24/11/26